Jathin Bandari - 03 Jul 2023 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
Chief Medical Officer
Signature
/s/ Mary Grendell, Attorney-In-Fact
Issuer symbol
TARA
Transactions as of
03 Jul 2023
Net transactions value
-$1,678
Form type
4
Filing time
05 Jul 2023, 16:05:35 UTC
Previous filing
20 Jan 2023
Next filing
12 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Tax liability $1,678 -682 -1.7% $2.46 38,460 03 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on July 1, 2020.